Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 602

1.

Evidence-based emergency medicine/critically appraised topic. Evidence behind the 4-hour rule for initiation of antibiotic therapy in community-acquired pneumonia.

Yu KT, Wyer PC.

Ann Emerg Med. 2008 May;51(5):651-62, 662.e1-2. doi: 10.1016/j.annemergmed.2007.10.022. Review.

PMID:
18272253
2.

Continuity of antibiotic therapy in patients admitted from the emergency department.

Shah MN, Schmit J, Croley WC, Meltzer D.

Ann Emerg Med. 2003 Jul;42(1):117-23.

PMID:
12827131
4.

The impact of emergency department crowding measures on time to antibiotics for patients with community-acquired pneumonia.

Pines JM, Localio AR, Hollander JE, Baxt WG, Lee H, Phillips C, Metlay JP.

Ann Emerg Med. 2007 Nov;50(5):510-6.

PMID:
17913298
5.

Effect of emergency department crowding on time to antibiotics in patients admitted with community-acquired pneumonia.

Fee C, Weber EJ, Maak CA, Bacchetti P.

Ann Emerg Med. 2007 Nov;50(5):501-9, 509.e1.

PMID:
17913300
6.

Audit of the management of patients admitted with community acquired pneumonia.

Foley SC, Kelly EM, O'Neill SJ.

Ir Med J. 2006 May;99(5):138-40.

PMID:
16892917
7.

Timing of antibiotic administration and outcomes for Medicare patients hospitalized with community-acquired pneumonia.

Houck PM, Bratzler DW, Nsa W, Ma A, Bartlett JG.

Arch Intern Med. 2004 Mar 22;164(6):637-44.

PMID:
15037492
8.

Effects of delayed oxygenation assessment on time to antibiotic delivery and mortality in patients with severe community-acquired pneumonia.

Blot SI, Rodriguez A, Solé-Violán J, Blanquer J, Almirall J, Rello J; Community-Acquired Pneumonia Intensive Care Units (CAPUCI) Study Investigators..

Crit Care Med. 2007 Nov;35(11):2509-14.

PMID:
17901833
9.

Azithromycin monotherapy for patients hospitalized with community-acquired pneumonia: a 31/2-year experience from a veterans affairs hospital.

Feldman RB, Rhew DC, Wong JY, Charles RA, Goetz MB; American Thoracic Society..

Arch Intern Med. 2003 Jul 28;163(14):1718-26.

PMID:
12885688
10.
11.

Processes of care, illness severity, and outcomes in the management of community-acquired pneumonia at academic hospitals.

Dedier J, Singer DE, Chang Y, Moore M, Atlas SJ.

Arch Intern Med. 2001 Sep 24;161(17):2099-104.

PMID:
11570938
12.

Effects of guideline-concordant antimicrobial therapy on mortality among patients with community-acquired pneumonia.

Mortensen EM, Restrepo M, Anzueto A, Pugh J.

Am J Med. 2004 Nov 15;117(10):726-31.

PMID:
15541321
13.

Treatment failure rates and health care utilization and costs among patients with community-acquired pneumonia treated with levofloxacin or macrolides in an outpatient setting: a retrospective claims database analysis.

Ye X, Sikirica V, Schein JR, Grant R, Zarotsky V, Doshi D, Benson CJ, Riedel AA.

Clin Ther. 2008 Feb;30(2):358-71. doi: 10.1016/j.clinthera.2008.01.023.

PMID:
18343274
15.

Use of indicators to evaluate the quality of community-acquired pneumonia management.

Nathwani D, Williams F, Winter J, Winter J, Ogston S, Davey P.

Clin Infect Dis. 2002 Feb 1;34(3):318-23.

PMID:
11774078
16.

Long-term morbidity and mortality after hospitalization with community-acquired pneumonia: a population-based cohort study.

Johnstone J, Eurich DT, Majumdar SR, Jin Y, Marrie TJ.

Medicine (Baltimore). 2008 Nov;87(6):329-34. doi: 10.1097/MD.0b013e318190f444.

17.

Outcome predictors of pneumonia in elderly patients: importance of functional assessment.

Torres OH, Muñoz J, Ruiz D, Ris J, Gich I, Coma E, Gurguí M, Vázquez G.

J Am Geriatr Soc. 2004 Oct;52(10):1603-9.

PMID:
15450034
18.

Antibiotic therapy and 48-hour mortality for patients with pneumonia.

Mortensen EM, Restrepo MI, Anzueto A, Pugh JA.

Am J Med. 2006 Oct;119(10):859-64.

PMID:
17000217
20.
Items per page

Supplemental Content

Support Center